Defunct Company
Total Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
563
NCT00119717
Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS)
Phase: Phase 3
Role: Lead Sponsor
Start: Jun 30, 2005
Completion: Jul 31, 2010
NCT00436592
Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients
Phase: Phase 1
Start: Feb 28, 2007
Completion: Jan 31, 2009
NCT01006993
Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator
Start: May 31, 2007
Completion: Jan 31, 2010
NCT00653536
A Study to Evaluate the Effects of the Neuroflo Device in People Who Have Had a Stroke
Role: Collaborator
Start: Mar 31, 2008
Completion: Jan 31, 2013